13 research outputs found
RYE BREEDING FOR LOW-PENTOSANS AND POSSIBILITY OF ITS USE IN ANIMAL FEEDING
The strategy and technology of rye breeding for low water-soluble arabinoxilans (WS-AX) in grain were proposed. Together with breeders from other institutions we developed the first six low-pentosan varieties of winter rye suitable for grain forage use. Seeds of low-pentosan forage rye do not form viscous mucus in animal stomachs, thus eliminating the problem that exists when feeding classic baking rye. When using them as fodder for laboratory and farming animals, high palatability and nutritional value were observed
Features of Psycho-Pedagogical Interaction with Parents of Primary School
На основе социологических и экспертных методов в статье исследуются особенности взаимодействия педагога-психолога с родителями учеников начальных классов с целью повышения эффективности оказания помощи учащимся и коррекции детско-родительских отношений как фактора учебной мотивации и условия успешности демографической политики.On the basis of sociological and expert methods, the article studies the features of interaction between a teacher-psychologist and parents of primary school students in order to improve the effectiveness of providing assistance to students and improving parental relations as a factor of educational motivation and the conditions for the success of demographic policy
Ieri, oggi e domani. Evidenze e prospettive dell\u2019interazione sul sistema renina-angiotensina. Lo scompenso cardiaco
LOVASTATIN EFFECT ON VASCULAR REMODELING AND MYOCARDIAL SYSTOLIC AND DIASTOLIC FUNCTION IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE
Aim. To study effect of 12-month therapy with lovastatin on vascular remodeling, systolic and diastolic functions of left ventricle (LV).Material and methods. 84 patients (54,3±6,5 y.o.) with ischemic heart disease (IHD) and dislipoproteinemia were involved in the study. Patients were randomized into 2 groups. Patients of the 1st group (n=44) received lovastatin (20-60 mg daily) in addition to hypolipidemic diet and standard therapy. Patients of the 2nd group (n=39) were treated with diet and standard therapy only. Lipid spectrum and transaminase blood levels estimation, carotid duplex ultrasonography, echocardiography were performed initially and after 12 months of treatment.Results. Decrease of carotid intima-media thickness, delay of increasing of LV myocardium mass index, increase of LV ejection fraction was observed in 12 months of treatment in patients of the 1st group. There were not any changes of LV diastolic function in both groups.The conclusion. In patients with IHD and dislipoproteinemia 12 month lovastatin therapy prevents of vascular remodeling and improves LV systolic function
2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy
Guidelines summarize and evaluate available evidence with the aim of assisting health professionals in selecting the best management strategies for an individual patient with a given condition. Guidelines and their recommendations should facilitate decision making of health professionals in their daily practice. However, the final decisions concerning an individual patient must be made by the responsible health professional(s) in consultation with the patient and caregiver as appropriate
2019 ESC Guidelines for the management of patients with supraventricular tachycardiaThe Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC).
[No abstract available
Hypertensive disorders in women with peripartum cardiomyopathy: insights from the ESC EORP PPCM Registry
Aims:
Hypertensive disorders occur in women with peripartum cardiomyopathy (PPCM). How often hypertensive disorders co-exist, and to what extent they impact outcomes, is less clear. We describe differences in phenotype and outcomes in women with PPCM with and without hypertensive disorders during pregnancy.
Methods:
The European Society of Cardiology PPCM Registry enrolled women with PPCM from 2012-2018. Three groups were examined: 1) women without hypertension (‘PPCM-noHTN’); 2) women with hypertension but without pre-eclampsia (‘PPCM-HTN’); 3) women with pre-eclampsia (‘PPCM-PE’). Maternal (6-month) and neonatal outcomes were compared.
Results:
Of 735 women included, 452 (61.5%) had PPCM-noHTN, 99 (13.5%) had PPCM-HTN and 184 (25.0%) had PPCM-PE. Compared to women with PPCM-noHTN, women with PPCM-PE had more severe symptoms (NYHA IV in 44.4% and 29.9%, p<0.001), more frequent signs of heart failure (pulmonary rales in 70.7% and 55.4%, p=0.002), higher baseline LVEF (32.7% and 30.7%, p=0.005) and smaller left ventricular end diastolic diameter (57.4mm [±6.7] and 59.8mm [±8.1], p<0.001). There were no differences in the frequencies of death from any cause, re-hospitalization for any cause, stroke, or thromboembolic events. Compared to women with PPCM-noHTN, women with PPCM-PE had a greater likelihood of left ventricular recovery (LVEF≥50%) (adjusted OR 2.08 95% CI 1.21-3.57) and an adverse neonatal outcome (composite of termination, miscarriage, low birth weight or neonatal death) (adjusted OR 2.84 95% CI 1.66-4.87).
Conclusion:
Differences exist in phenotype, recovery of cardiac function and neonatal outcomes according to hypertensive status in women with PPCM